Longevity today is not just about adding years, but about expanding the quality of life—health, vitality, clarity, and purpose. LiveBeyond applies science, clinical expertise, and strategic insight to help shape a world where more people can live longer, and live well.
Vision
Mission
To empower individuals and organizations by facilitating access to advanced longevity research and medical solutions. We are committed to scaling these innovations, helping our partners lead the future of healthcare by making extended healthy lifespans a reality for all.
To keep our partners at the forefront of the rapidly growing longevity sector. Through expert-led research, education, and collaboration, we make advanced longevity solutions accessible and actionable for all.
We build on six key pillars.
At LiveBeyond, we specialize in offering a range of services designed to elevate longevity practices and empower businesses to lead in the rapidly growing longevity sector. Our services are built around the idea of maximizing health span—ensuring that longer lives are lived with energy and vitality.
✻
The next generation of biological clocks is here and finally ready for clinical use. Unlike traditional DNA methylation clocks that suffer from instability and unclear relevance, Bioclock solutions use routine clinical biomarkers to deliver reliable, trackable biological age insights. We help clinics and research teams implement this tool seamlessly into their existing workflows, unlocking precision diagnostics, real-time intervention tracking, and actionable longevity intelligence.
✻
Bio-Tech has entered the longevity space, realizing the immense potential, but as this sector emerges, the strategies for effective longevity enhancement and financial success remain opaque. We help biotech companies navigate the landscape, translating scientific approaches to target aging and age-related diseases into viable investment plans and clinical research schemes to get to market.
✻
As one of the fastest-growing sectors in biotech, the longevity field presents vast opportunities. We guide investors through this complex landscape, providing a comprehensive analysis of pharmaceuticals, diagnostics, and supplements. While hugely promising, the longevity industry faces unique challenges ranging from credibility issues to an emerging regulatory environment. Our expertise helps identify the most promising opportunities, shaping the future of health and wellness.
✻
We partner with leading longevity clinics worldwide to enhance their credibility, providing expert advice on delivering personalized healthspan extension services. Through data-driven insights, we help clinics develop longevity prescriptions tailored to their clients' unique needs, backed by the latest scientific advancements in age-reversal therapies, regenerative treatments, and preventive healthcare.
✻
How do you engage with a wide array of longevity interventions and diagnostics, many of which show promise but lack classical validation through clinical studies? This can be a bewildering question even to informed individuals and scientists. We can work together to offer personalized strategies to modify your biological age and measure outcomes.
✻
We collaborate with leading consumer brands and other longevity companies in integrating scientifically-backed longevity innovations into their products, making breakthrough solutions accessible to everyday consumers and enhancing brand value.
Our Signature Program
✻
We help clinics design, launch, and scale credible longevity programs with clinical protocols, operational frameworks, and expert positioning.
✻
We provide validated tools to measure, track, and apply biological age in practice— supporting age-driven decisions and care strategies.
✻
We guide investors with scientific validation, sector analysis, and research-backed tools to make credible, highimpact longevity bets.
Our team of experts are our greatest asset.
Board of Directors
Brian Kennedy
Board Member
Dr. Brian Kennedy is a globally renowned expert in the biology of aging, specializing in translating research into interventions that delay and prevent age-related diseases. He is a Distinguished Professor at the National University of Singapore and leads groundbreaking longevity research programs focused on extending human lifespan and health span.
Julie Ying Baron
Board Member
Julie Ying Baron brings a unique blend of expertise in space exploration, commodities trading, and longevity.
As co-founder of LiveBeyond, she aligns her passion for human health with her vision for sustainable living, bridging the gap between cutting-edge science and real-world business applications in longevity and wellness innovation.
Jan Gruber
Board Member
Dr. Jan Gruber is an Associate Professor at the Yong Loo Lin School of Medicine, NUS, where he leads research on aging mechanisms and biomarkers. With a background in applied mathematics and biochemistry, he focuses on pharmacological interventions and developing human aging clocks using computational models. Dr. Gruber is also committed to education and mentorship in the longevity field.
Longevity Experts
Matt Kaeberlein
Aging Biology & Longevity Interventions
Dr. Matt Kaeberlein is the Chief Executive Officer at Optispan, Inc. and host of the Optispan Podcast. He is also an Affiliate Professor of Oral Health Sciences at the University of Washington and a Co-Founder of both the Dog Aging Project and Dog Aging Institute. Dr. Kaeberlein is deeply committed to advancing human and animal health by developing new technologies for health optimization and targeting the biological processes underlying aging and age-related disease.
Evelyne Bischof
Longevity Medicine & AI-Driven Precision Health
Dr. Evelyne Bischof is a longevity and internal medicine expert with over a decade of clinical experience across Switzerland, the U.S., and China. A professor at Shanghai University of Medicine and Tel Aviv University, her research focuses on precision medicine, AI, and biogerontology. She has authored over 80 peer-reviewed papers and speaks globally on medical innovation.
Peter Mullen
Metabolic Regulation in Aging
& Disease
Dr. Peter Mullen is a renowned expert in the biology of aging, focusing on how metabolism influences aging and age-related diseases. He leads research at the Leonard Davis School of Gerontology and Keck School of Medicine, USC. With nearly 30 publications in prestigious journals, he has received numerous awards and serves on key metabolic health journal editorial boards.
Rebekah Granger-Ellis
Cognitive Aging &
Neuroscience
Rebekah Granger Ellis is an expert in neuroscience and systems change, focusing on leadership, behavioral change, and neurowellness. With 20 years of experience, she merges neuroscience with organizational strategies to enhance executive functioning and global team performance. Rebekah has led transformational programs for C-suites, governments, and policymakers worldwide, fostering resilience and future-ready systems.
Vincenzo Sorrentino
Supplement & Aging
Mechanism
Dr. Vincenzo Sorrentino is an Assistant Professor at the Yong Loo Lin School of Medicine, National University of Singapore, specializing in aging, mitochondrial biology, and neuromuscular degeneration. His research focuses on NAD+ metabolism and mitochondrial function in Alzheimer’s disease and muscle aging. Vincenzo has led groundbreaking studies, including the discovery of trigonelline as a novel NAD+ precursor.
Chong He
Aging-Related Drug Discovery
& Protein Engineering
Dr. Chong He holds a PhD in Biochemistry from Peking University and has over 15 years of experience in drug discovery and development, focusing on aging-related diseases. Currently, as director of a biopharma drug discovery team, Dr. He leads efforts to translate cutting-edge research into innovative therapeutics targeting the molecular mechanisms of aging.
Max Unfried
AI-Driven Longevity Research
Dr. Max Unfried holds a position as a Research Fellow with the Centre for Healthy Longevity at the National University of Singapore where he has focused his research on the systems biology of aging, exploring biomarkers of cellular health and rejuvenation. He also serves as Scientific Director of The Thalion Initiative, a research-driven effort addressing fundamental questions of aging biology. Operating at the confluence of Artificial Intelligence, Complex Systems, and Molecular Biology, Max has used his expertise to bridge the world between academic science and the business of science, and serves as a trusted scientific advisor to startups, venture capital firms, and family offices. A respected voice in the longevity community, Max often shares his insights and findings as a speaker and panelist at notable longevity conferences worldwide. His dedication to the field has not only fostered rich discussions and propelled science forward but also earned him awards recognizing his significant contributions to the longevity field.
Olivia Ly Lesslar
Longevity Medicine Neuroplasticity & Complex Chronic Conditions
Dr. Olivia Ly Lesslar is a medical doctor specializing in longevity medicine, psychoneuroimmunology, and complex multisystem conditions. She collaborates with leading international clinics, curating personalized programs that integrate neuroplasticity techniques, advanced therapies, and precision nutrition. She is a faculty lecturer at the Geneva College of Longevity Science, an Adjunct Senior Lecturer at Griffith University’s National Centre for Neuroimmunology and Emerging Diseases, and the Research Lead at the British College for Functional Medicine. A sought-after speaker, she has presented at Oxford University’s Smart Ageing Summit, Berkeley University, and TEDx Melbourne. Recognized as an industry leader, she was featured in NYC Journal’s 50 Under 50 list and serves as Science Director at Sens.ai, Chief Medical Officer at Atlus, and a medical advisor to multiple longevity-focused organizations.
Xianmin Zeng
Stem Cell Therapy & Regenerative Approaches for Longevity
Dr. Xianmin Zeng is a renowned expert in stem cell biology and neurobiology. A biotech entrepreneur who authored over 100 peer-reviewed publications and several issued patents, Dr. Zeng is the Founder and Chief Executive Officer of RxCell Inc, a biotechnology company developing cell-based therapies for aging-related degenerative diseases and healthy longevity. She was Professor at the Buck Institute in California in 2005-2018 where she built and directed the Institute’s Stem Cell Program.
Vera Gorbunova
Comparative Biology & Genetic Mechanisms of Longevity
Dr. Vera Gorbunova is an endowed Professor of Biology at the University of Rochester and co-director of the Rochester Aging Research Center. A pioneer in comparative biology for aging research, she has uncovered key mechanisms linking genome stability, tumor suppression, and longevity across species. Her groundbreaking work has earned prestigious awards, including the Cozzarelli Prize from PNAS, the Prince Hitachi Prize in Comparative Oncology, and awards recognition from the Ellison Medical Foundation, the Glenn Foundation, and the National Institutes of Health. Dr. Gorbunova holds a PhD from the Weizmann Institute of Science and continues to shape the field of longevity science through her research on exceptionally long-lived mammals.
Yousin Suh
Genomics, Epigenetics & Genetic Resilience in Longevity
Dr. Yousin Suh is the Charles and Marie Robertson Professor of Reproductive Sciences at Columbia University, where she directs research on reproductive aging and the genetic mechanisms underlying longevity and age-related diseases. Her work has identified rare genetic variants linked to extreme longevity, sirtuin mutations associated with heart disease risk, and epigenetic signatures of cellular senescence. Using advanced functional genomics approaches, she investigates genetic resilience to aging across diverse populations. Recognized with the Glenn Award for Research in Biological Mechanisms of Aging, Dr. Suh plays a key role in shaping the field through international symposiums, editorial leadership, and advisory positions in leading research institutions.
Ana Baroni
Personalized Longevity Strategies, Innovations in Healthspan Science
With over 25 years of experience in longevity, regenerative, integrative, functional, and precision medicine, Ana Baroni holds an MD, PhD, and six MSc degrees. She serves as Chief Science Officer at LongevityTech.fund and Chief Medical Officer at HealthyLongevity.clinic, while also contributing as a Medical Advisory Board member for longevity at Purehealth. Ana’s expertise includes evaluating R&D projects for the European Commission and judging the National Academy of Medicine's Healthy Longevity Challenge. She offers scientific consultancy and advisory support across biotech sectors and government initiatives in the US, EU, and Middle East. Additionally, Ana shares her knowledge as a lecturer in the Master in Longevity program at Barcelona University, focusing on healthy aging both on Earth and for space travelers.
Andrei Seluanov
Longevity Mechanisms & Comparative Biology
Zongmin Liu
AI Health Longevity Research
Dr. Andrei Seluanov is a Professor of Biology and Medicine at the University of Rochester, specializing in the science of aging and genome stability. His research explores how some long-lived mammals, like the naked mole rat, naturally resist cancer and age-related decline. By studying DNA repair and tumor suppression across species, Dr. Seluanov uncovers clues to how evolution shapes longevity. His work is widely published in journals such as Nature and Science, and continues to shed light on the biological pathways that influence lifespan.
Dr. Zongmin Liu holds a position as a Research Fellow with the Centre for Healthy Longevity at the National University of Singapore. Her research focuses on AI healthy longevity, exploring AI-powered approaches to discover longevity compounds and develop multi-omic aging biomarkers from blood, gut microbiome, and phenotypic data that could reveal aging patterns before they manifest. This work bridges computational drug discovery with experimental validation and clinical trial design, investigating how algorithms might transform aging from an inevitable decline into something we can predict, prevent, and modify.
Services
